Pelthos Therapeutics to Participate in Upcoming September Investor Conferences

Rhea-AI Summary

Pelthos Therapeutics (NYSE American: PTHS) announced its participation in two upcoming investor conferences in September 2025. The company's CEO Scott Plesha and CFO Frank Knuettel II will represent Pelthos at the H.C. Wainwright 27th Annual Global Investment Conference in New York City and the Investor Summit Group Q3 Virtual Conference.

At the H.C. Wainwright conference, scheduled for September 8-10, 2025, management will deliver a presentation on September 10 at 10:30 A.M. ET and will be available for one-on-one meetings. The virtual Investor Summit Group conference will take place on September 16-17, 2025. A webcast of the H.C. Wainwright presentation will be available on Pelthos' website with a 90-day replay period.

News Market Reaction

+13.96%

11 alerts

+13.96% News Effect

+7.8% Peak Tracked

-2.9% Trough Tracked

+$12M Valuation Impact

$98M Market Cap

1.0x Rel. Volume

On the day this news was published, PTHS gained 13.96%, reflecting a significant positive market reaction. Argus tracked a peak move of +7.8% during that session. Argus tracked a trough of -2.9% from its starting point during tracking. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $12M to the company's valuation, bringing the market cap to $98M at that time.

Data tracked by StockTitan Argus on the day of publication.

DURHAM, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today announced that Scott Plesha, CEO, and Frank Knuettel II, CFO, will participate in the upcoming September conferences: H.C. Wainwright 27th Annual Global Investment Conference and the Investor Summit Group Q3 Virtual Conference.

Investor Conference Details:

H.C. Wainwright 27th Annual Global Investment Conference
Location: Lotte New York Palace Hotel, New York City
Conference Dates: September 8-10, 2025
Presentation Date: September 10, 2025 at 10:30 A.M. ET
One on one meeting availability: September 10, 2025

Institutional investors interested in scheduling an in-person one-on-one meeting should contact their institutional sales rep or register for the conference via this LINK.   

A webcast of the presentation will be available on the Events and Presentations pages of Pelthos’ website at https://pelthos.com. Archived replays will be available for 90 days following the event.

Investor Summit Group Q3 Virtual Conference
Location: Virtual
Conference Dates: September 16-17, 2025

To register for this event please visit this LINK.

About Pelthos Therapeutics
Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens. The company’s lead product ZELSUVMI™ (berdazimer) topical gel, 10.3%, for the treatment of molluscum contagiosum, was approved by the U.S. Food and Drug Administration in 2024. More information is available at www.pelthos.com. Follow Pelthos on LinkedIn and X.

Contacts

Pelthos Investor Inquiries:
Mike Moyer
Managing Director, LifeSci Advisors, LLC
mmoyer@lifesciadvisors.com

Media:
KWM Communications
Kellie Walsh / Rachel Kessler
pelthos@kwmcommunications.com
(914) 315-6072

FAQ

When is Pelthos Therapeutics (PTHS) presenting at the H.C. Wainwright Conference 2025?

Pelthos Therapeutics will present on September 10, 2025 at 10:30 A.M. ET at the Lotte New York Palace Hotel.

Where can I watch Pelthos Therapeutics' (PTHS) H.C. Wainwright conference presentation?

The presentation webcast will be available on the Events and Presentations page of Pelthos' website (pelthos.com), with replays available for 90 days after the event.

Which executives from Pelthos Therapeutics (PTHS) will attend the September 2025 investor conferences?

CEO Scott Plesha and CFO Frank Knuettel II will represent Pelthos Therapeutics at both conferences.

What investor conferences is Pelthos Therapeutics (PTHS) attending in September 2025?

Pelthos is attending the H.C. Wainwright 27th Annual Global Investment Conference (September 8-10) and the Investor Summit Group Q3 Virtual Conference (September 16-17).